The Variation of SARS-CoV-2 and Advanced Research on Current Vaccines
Over the past 2 years, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the coronavirus disease 2019 (COVID-19) and rapidly spread worldwide. In the process of evolution, new mutations of SARS-CoV-2 began to appear to be more adaptable to the diverse changes of various cellula...
Main Authors: | Yao Jiang, Qian Wu, Peipei Song, Chongge You |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.806641/full |
Similar Items
-
A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants
by: Ali A. Rabaan, et al.
Published: (2022-10-01) -
Anti-SARS-CoV-2 Vaccines and Monoclonal Antibodies Facing Viral Variants
by: Ahlam Chaqroun, et al.
Published: (2021-06-01) -
Scope of SARS-CoV-2 variants, mutations, and vaccine technologies
by: Josephine Wambani, et al.
Published: (2022-03-01) -
Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions
by: Ahmed I. Abulsoud, et al.
Published: (2023-01-01) -
The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
by: Gary McLean, et al.
Published: (2022-04-01)